Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting

The gut microbiota of mammals possess distinctive metabolic pathways with untapped therapeutic potential. Using molecular insights into dietary fiber metabolism by the human gut microbiota, we designed a targeted drug delivery system, called GlycoCaging, that is based on bespoke glycoconjugates of a complex plant oligosaccharide. GlycoCaging of exemplar anti-inflammatory drugs enabled release of active molecules triggered by specific glycosidases of autochthonous gut bacteria. GlycoCaging ensured that drug efficacy was potentiated, and off-target effects were eliminated in murine models of inflammatory bowel disease. Biochemical and metagenomic analyses of gut microbiota of individual humans confirmed the broad applicability of this strategy.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-05-01
DOI
https://doi.org/10.1126/science.adk7633
Citations
11
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
8.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting

Benjamin Wei‐Qiang Hui, Tara Shelton, Paul E. Moote, D. Wade Abbott et al.
11 citations
Science
Gut microbiota and health
8.87
article

Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting

Benjamin Wei‐Qiang Hui, Tara Shelton, Paul E. Moote, D. Wade Abbott, G. Douglas Inglis, Matthew Luzentales-Simpson, Changlin Wang, Danisa M. Bescucci, Jagatheeswaran Kothandapani, Jenny F. Gusse, Xiaohui Xing, Deanna L. Gibson, M Lange, Susan C. Menzies, Julie M. Grondin, Eric C. Martens, Natasha Haskey, Kathaleen E. House, Laura M. Sly, Sandra T. Clarke, Harry Brumer, Alexander S. C. Fraser, Wei Jen
article en
11 citations

Abstract

The gut microbiota of mammals possess distinctive metabolic pathways with untapped therapeutic potential. Using molecular insights into dietary fiber metabolism by the human gut microbiota, we designed a targeted drug delivery system, called GlycoCaging, that is based on bespoke glycoconjugates of a complex plant oligosaccharide. GlycoCaging of exemplar anti-inflammatory drugs enabled release of active molecules triggered by specific glycosidases of autochthonous gut bacteria. GlycoCaging ensured that drug efficacy was potentiated, and off-target effects were eliminated in murine models of inflammatory bowel disease. Biochemical and metagenomic analyses of gut microbiota of individual humans confirmed the broad applicability of this strategy.

ScienceVol. 388(6754)
Agriculture and Agri-Food Canada (CA), University of Michigan (US), Canada's Michael Smith Genome Sciences Centre (CA), BC Children's Hospital (CA), Okanagan University College (CA)
Good health and well-being
Openalex Percentile: Top 2%
Gut microbiota and health
8.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.